biotech

FDA Approxes ATryn, First Drug from a Genetically Engineered Animal

Filed in archive Diagnostics, Methodologies and Instrumentation , Genomics, Proteomics and Bioinformatics , Other Biotechnology News on February 6, 2009

FDA Approxes ATryn, First Drug from a Genetically Engineered Animal
The Food and Drug Authority has approved ATryn, the first ever transgenically produced therapeutic protein and the first recombinant antithrombin approved in the U.S.

ATryn is indicated for the treatment of patients with hereditary antithrombin deficiency, undergoing high-risk surgical or childbirth procedures. GTC Theapeutics has collaborated with OVATION Pharmaceuticals, Inc. to develop and market ATryn® in the United States.



Permalink: FDA Approxes ATryn, First Drug from a Genetically Engineered Animal

Tags: transgenics  atryn  genetics  genetic+engineering  antithrombin  blood+clotting  section  noscript+section 

Vote for FDA Approxes ATryn, First Drug from a Genetically Engineered Animal:

  • Currently 9.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 9.00 out of 1 vote(s) cast.
 
Share It
RSSrss
Google google
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Tagcloud
Most Popular   Best of   Biotech Hubs and Facilities   Biotech/Science Blogs   Corporate and Industrial News   Diagnostics, Methodologies and Instrumentation   Did you know   Drugs, Vaccines and Therapeutics   Energy, Environment and Ecology   Food and Agriculture   Gene Therapy   Genomics, Proteomics and Bioinformatics   Information About   Meetings and Other Events   Microbiology   Misc   Nanomedicine   Other Biotechnology News   Patents and Intellectual Property Rights   Quick introduction   Stem Cells